|
|||||
Neurological
Basis of Behavior (PSY -
610)
VU
Lesson36
Basic
Neurochemistry
Objectives:
To
familiarize the students with
the
Various
NT and their role in the modulation of
behaviors
Classification
of Neurotransmitters. Monoamines:
Catechoalimnes
and
Indolemaine,
acetylcholine,
amino acid, and Peptide
Neurotransmitters
role in modulation of behaviors and
Aberration
Drugs
and Behavior:
Classification
of Psychopharmacological substances
Behavioral
correlates, Treatment:
Mechanism
of synaptic transmission
Major
Neurotransmitter: Acetylcholine
(continued)
ACH
and Behaviors.
As
we have discussed in the last lesson, Ach
has a unique and important
neurotransmitter role in the
brain.
Without the normal levels of
Ach and its receptors
working effectively the brain
would not be
able
to command the muscles of the
body.
1.
Arousal: Ach
has an important role as
excitant of neural activity.
This means that
brain
electrical
activity is aroused and can
be monitored by the Electtroencepaholographic
(EEG)
recordings.
When ACH is injected intravenously or
applied to cortex it leads to
increased EEG
activity.
Further, when anticholinergics
are administered as they
block and reduce Ach levels
in
the
brain, the EEG arousal is also
blocked. Interestingly, this
does not affect the
behavioral
arousal).
Ach is involved in sleeping and
awakening via the locus coerreleus,
which may
explain
the involvement of Ach in brain
electrical activity arousal.
2.
Drinking:
Ach
is important in drinking and fluid
regulation. The regulation of the
water intake
takes
place via the Ach mechanism.
The cellular dehydration is mediated by
the cholinoceptive
system
of neurons in the preoptic area of the
hypothalamus. They monitor the
extracellular
space
for volumetric changes
(changes in the volume of fluid) produced
after changes in
isotonic
body fluids. (Whenever the
intracellular membrane runs short of
fluid it takes in
fluids
from
the extracellular membrane, as the
survival of cell is more important!).This
leads to the
release
of Renin from kidneys which
lead to increased formation of
Angiotensin which
then
stimulates
the neurons in the preoptic area. Thus,
this communication goes from
the brain to the
kidneys
and back leading to an increase in fluid
and salt intake. The messages
begin with the
Cholinoceptive
receptors sending out the signals.
3.
Sham rage and attack:
Sham
rage is the physical appearance of
rage without an object of
rage
in
front of the animal (cats
and rats). In cats rage
appears in hissing and spitting, and
raised hair
on
the dorsal surface of the body and the
tail. Sham rage is induced
in cats and rats by
the
cholinergic
stimulation of amygdala and septum.
Aggression is also produced by
midbrain
ventral
tegmental area. Further, the
killing attack pathways in rat (of
mice) and cat (of rats)
are
cholinergically
organized. The cholinergic
stimulation of amygdala, LH,
midbrain tegmental
regions
leads to a quiet biting attack in
rat and cats. How do we
know? This attack is blocked
by
atropine
4.
Punishment:
Reinforcing
stimuli increases the probability of a
response to it whereas
punishing
stimuli decreases the probability of a
response to it. The
intracranial self
stimulation
138
Neurological
Basis of Behavior (PSY -
610)
VU
is
part of the reward systems and
reinforcing so an animal would keep
self stimulating for
its
own
reward. On the other hand, the
periventricular area in hypothalamus
part of punishment
systems.
The ventromedial hypothalamus is
part of this punishment
system. Rats
previously
trained
for Variable Interval Schedule
(VIS) for food are
run in an experiment where
every
response
is followed by a shock. (Remember VIS is
when the time between
reinforcement
varies!).
When every response is
followed by a shock, a reduction in VIS
response follows. If
we
lesion the Ventromedial nuclei
(VMN), it leads to increase in the
response which had
been
depressed
(leads to disinhibition). Anti
Ach also does the same,
which is they lead to
an
increase
in disinhibition of the punished response.
Inhibition of punished response means
the
animal
would stop responding, but
disinhibition means that the
response would return as
the
inhibitor
has been blocked. AntiAch
are involved in removing the
inhibition.
5.
Alzheimers: Alzheimer's
is a disease of old age where
degeneration of brain takes place to
a
point
where the person cannot carry out
any function. The important
feature of this disease
is
loss
of memory. Recently muscarinic receptor
agonists have been used in the treatment
of
Alzheimer's
disease. This replaces
depleted Ach in the basal
forebrain as the neurons in this
area
degenerate.
Another treatment of Alzheimer's patients is
administration of acetylcholinesterase
inhibitors
this increases levels of ACH in
the synapse as the breakdown is
blocked), thereby
increasing
cholinergic activity in damaged
brain areas. Physostigminewas used
earlier but
results
indicated strong side effects.
Tetrahydroaminoacridine (THA, or
tacrine), first
cholinesterase
inhibitor which has been
approved for Alzheimer's patients.
Patients given THA
shown
some reduction of Alzheimer's
symptoms were able to resume
normal activity.
However,
not all patients can use it
as it has strong side effects on increasing
liver enzymes.
Ach
is also involved in learning,
memory, motor behaviors (it
works in balance with DA
for
Parkinson's
and other motor disorders), in pain, in
coordination with brain
opioids.
Other
NT's
In
addition to the neurotansmitters, we have discussed so
far, the Catecholamines, the
Indolamine,
and
Acetylcholine; there are other
neurotransmitters which are active
within the CNS. We
will
discuss
them in brief.
1.
Glutamic acid: Glutamate
and GABA are found in simple
organisms. The first
neurotransmitter
to
be evolved in the brain is Glutamate.
Glutamate is an excitatory
neurotransmitter, its
receptors
found
all over the brain. Chinese
food contains a large amount of
Monosodium Glutamate.
There
are
three types of receptors: NMDA, quisquilate and the
kainite receptors. The
receptors are all
important
in working with other
NTs
2.
GABA.
Gamma Amino butyric acid
was first synthesized in
1883 known to be a metabolite
of
plant
and microbial metabolism. It was discovered in the
mammalian brain in the 1950's, and
in
very
high concentrations in the brain and the
spinal cord. In the brain GABA is
found in amounts
10-15
times greater than DA, NE or 5HT
also a minuscule amount
found in the retina. Even
till now
it
is not very extensively
studied. It is generally classified as an
inhibitory NT and accounts
along
with
other amino acids for a
major part of the neuronal transmission.
GABA works to balance the
monoamines
DA, NA and 5HT wherever they
are involved. GABA is implicated
directly in
Huntington's
chorea which is due to degeneration of
GAB Aminergic neurons. GABA is
indirectly
involved
in Parkinson's, Epilepsy (abnormality in
the biochemistry of GAB Aminergic
neurons)
and
Schizophrenia
GABA
Synthesis; This
involves only two steps: one
to synthesize it and one to break it
down:
1.
One step synthesis from
its amino acid precursor
Glutamic Acid which is decarboxylased by
the
enzyme
Glutamic
acid decarboxyalse.
139
Neurological
Basis of Behavior (PSY -
610)
VU
Glutamic
acid--------------------GABA
Glutamic
acid decarboxylase (GAD) and coenzyme
pyroxidal phosphate, this process
can be
blocked
by ions such as chloride and
zinc.
2.
Catabolism: GABA--is trans-aminated by GABA-A-oxoglutarate
transaminase. GABA
is
transformed
into Succinic Acid
Semialdehyde to return back into the
Krebs cycle
In
the transaminase process- GABA conversion
is reversed to Glutamic acid
through alpha
ketoglutarate
which
acts as amine acceptor.
Distribution
and pharmacological
agents
From
monkey to human brain 1968-1971
studies showed the highest
GABAminergic concentrations
in
the Substantia Nigra (SN) Globus
Pallidus (GP), and the Hypothalamus
(hyp)
Agonists:
The
post receptor GABA agonist is muscimol.
This leads to increased arousal,
self
mutilation,
increased feeding if placed in the
hypothalamus (disinhibition of
inhibition)
Antagonists:
Post
receptor antagonist or receptor blockade by picrotoxin
and bicuculine.
Benzodiazepines
(Valium and Librium)
stimulate a particular site of GABA
Aminergic neurons.
This
alleviates the anxiety
symptoms/response.
Glycine:
is
another Inhibitory neurotransmitter like
GABA however research is still
ongoing to
identify
its role. It is found in the
mammalian spinal cord and the
brain. It is found in greater
amounts
in the spinal grey matter than the
brain. Suggesting it may be working
with the interneuron.
However,
no distinct and clear glycine pathways in the
brain
Strychnine
(poison) blocks the action of
glycine and also blocks postsynaptic
inhibition.
PEPTIDES:
neuroactive
peptides are candidates for
neurotransmitters. Some of these are
like
orthodox
NT's, some are performing
modulatory or regulatory roles, and that
these also act as
neurohormones.
BRAIN
OPIOIDS, ANGIOTENSIN II, (thirst)
Oxytocin and Vasopressin, Leutenizing
Hormone
Releasing
Hormones (LH-RH), Substance P and
Adreno-Corticotropic Hormone
(ACTH)
Brain
Opioids: Endorphins
(large molecules) and Enkephalins
(smaller molecules):
Hughes
and Kosterlitz (1975) in Aberdeeen
discovered the existence of brain opioids in the
brain.
This
was a landmark finding
because for the first time
it was found that this
chemical compound
was
similar in composition to the opiates
morphine, heroin etc. In
later researches, Huda Akil
and
her
research group reported that
the highest concentration in Substantia
Nigra, lateral
hypothalamus,
cerebral
Cortex, Periaquaductal gray.
Extracts
taken out from the brain,
when administered to laboratory animals
led to analgesia, wet
dog
shakes
upon application (in a
manner similar to administration of
opiates).Similarly, akinesia,
hypothermia,
rigidity, catalepsy were also
seen.
The
question is whether brain
opioids are natural
neuroleptics or not (neuroleptics
are antipsychotic
drugs).
140
Neurological
Basis of Behavior (PSY -
610)
VU
In
some cases psychotic patients
who are not responding to
other treatment drugs
(neuroleptics)
have
responded short term endorphin treatment
(Mcgreer and Mcgreer
1980).
These
are also involved in emotions,
growth, pleasure (acting
through the mesolimbic DA
pathways),
stress induced analgesia (Akil et al
1975), growth and development
(Najam and
Panksepp
1980).
Opioid
antagonists have also been found
effective in treatment of autism and childhood
disorder (
Panksepp
et al's theory of brain
opioids and attachment states that
brain opiates are
natural
conforters
in the brain, it is when they
are blocked that the addicts
turn to morphine/heroin, and
autistic
children have higher than
normal brain opiate level
therefore). The discovery
that pain and
acupuncture
pathways are similar to brain
opioids pathways in the body and spinal
cord provide
strong
evidence for the involvement of brain
opiates in the pain and acupuncture.
Narcotic
analgesics
such as morphine heroin are
severely addictive and have a high
tolerance value are
potent
analgesiscs,
potent anti congestion, and also
for stomach and digestive
problems. The interesting
aspect
of opiates effect on pain is that it is
only the affective component which is
reduced (one does
not
feel the pain) the physical component is
still there. Pain is still there
but the patients do not
care
about
it, the reaction to pain is
diminished.
Psychotogenic
compounds
Hallucinogens:
1.
LSD is a potent
drug in fact so potent that
a small dose of 1/10,000 gram is
effective. This has
great
tolerance to the point that the same
dose is not effective if
taken 2nd time which means
an
increased
dosage needed every time
for an effect to take place.
The LSD "trip" depends on
the
mood
and personality of the user and can be
controlled
2.
Mescaline also
hallucinogenic compound made from plants
extracts in Mexico. It is used in
religious
ceremonies by tribes in
Mexico
Psychopharmacology
This
area of specialization is the study of
the effects of drugs on psychological processes. It is
both a
basic
and an applied science. " A recognition
of the interrelationships between
pharmacological
agents,
neuro regulators, and behavior
has become essential for
those involved in
helping
individuals
who have psychiatric disorders"
Therefore in order to develop drugs
research in the
laboratory
is needed before the drugs can be
tested and used- especially on
humans.
The
evidence is provided when the symptoms of a psychiatric disorder are removed
linked to
neurotransmitter,
and then the normalization of behavior should occur with normalization of levels
of
NT
in the brain. Further, known effective exogenous substances should have similar
chemical effects
as
the endogenous (brain) chemicals. Pharmacological substances should be able to
interact with NTs
at
a given sites if they have the same chemical composition.
References
1.
Kalat J.W (1998) Biological
Psychology Brooks/ Cole
Publishing
2.
Carlson N.R. (2005) Foundations of
Physiological Psychology Allyn and Bacon,
Boston
3.
Pinel, John P.J. (2003)
Biopsychology (5th edition) Allyn and Bacon
Singapore
4
Bloom details later
5.
Bridgeman,B (1988)The Biology of
Behavior and Mind. John Wiley
and Sons New
York
6.
Seigel,G.J. ( Ed. in chief) Agranoff, B.W, Albers W.R. and Molinoff, P.B. (Eds.)
Basic
Neurochemistry:
Molecular, Cellular and Medical Aspects
141
Neurological
Basis of Behavior (PSY -
610)
VU
7.
Cooper, J.R... Bloom, F.E and
Roth H.R. (1978): The
Biochemical basis of Neuropharmacology
(3rd
Edition),
Oxford University Press,
UK
142
Table of Contents:
|
|||||